ANDA 78915, held by Mylan. Polyethylene Glycol 3350.
As of Nov 16, 2026, ANDA 78915 (Polyethylene Glycol 3350), held by Mylan, was first approved by FDA on Oct 6, 2009, with 4 approved supplements and 0 published complete response letters.
Use
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 6, 2009 | Original application | Approved |
| Polyethylene Glycol 335017GM/PACKET · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Polyethylene Glycol 335017GM/SCOOPFUL · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Nov 2, 2022 | Supplement 2Labeling · Standard review | Approved | None posted |
| Nov 2, 2022 | Supplement 6Labeling · Standard review | Approved | None posted |
| Nov 2, 2022 | Supplement 7Labeling · Standard review | Approved | None posted |
| Nov 2, 2022 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 6, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters